94 related articles for article (PubMed ID: 17525629)
1. The cytoskeletal proteins alpha-actinin, Ezrin, and talin are De-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium.
Slater M; Cooper M; Murphy CR
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):170-4. PubMed ID: 17525629
[TBL] [Abstract][Full Text] [Related]
2. Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma.
Slater M; Cooper M; Murphy CR
Acta Histochem; 2006; 108(1):13-8. PubMed ID: 16564564
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
4. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma.
Ohtani K; Sakamoto H; Rutherford T; Chen Z; Kikuchi A; Yamamoto T; Satoh K; Naftolin F
Cancer Lett; 2002 May; 179(1):79-86. PubMed ID: 11880185
[TBL] [Abstract][Full Text] [Related]
5. Haptoglobin expression in endometrioid adenocarcinoma of the uterus.
Nabli H; Tuller E; Sharpe-Timms KL
Reprod Sci; 2010 Jan; 17(1):47-55. PubMed ID: 19801537
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
7. Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?
Cochrane DR; Tessier-Cloutier B; Lawrence KM; Nazeran T; Karnezis AN; Salamanca C; Cheng AS; McAlpine JN; Hoang LN; Gilks CB; Huntsman DG
J Pathol; 2017 Sep; 243(1):26-36. PubMed ID: 28678427
[TBL] [Abstract][Full Text] [Related]
8. Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas.
Köbel M; Langhammer T; Hüttelmaier S; Schmitt WD; Kriese K; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
Mod Pathol; 2006 Apr; 19(4):581-7. PubMed ID: 16554733
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus.
Ervine A; Leung S; Gilks CB; McCluggage WG
Histopathology; 2014 May; 64(6):840-6. PubMed ID: 24267480
[TBL] [Abstract][Full Text] [Related]
10. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
Younes SF; Aiad H; Kandil M; El Kalashy FS
Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract][Full Text] [Related]
13. Regulation and activation of ezrin protein in endometriosis.
Ornek T; Fadiel A; Tan O; Naftolin F; Arici A
Hum Reprod; 2008 Sep; 23(9):2104-12. PubMed ID: 18552365
[TBL] [Abstract][Full Text] [Related]
14. Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor II: to a link between endometriosis and endometrioid ovarian cancer.
Keita M; AinMelk Y; Pelmus M; Bessette P; Aris A
J Obstet Gynaecol Res; 2011 Feb; 37(2):99-107. PubMed ID: 21083841
[TBL] [Abstract][Full Text] [Related]
15. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
[TBL] [Abstract][Full Text] [Related]
17. Testosterone Aromatization to Estradiol in Course of Ovarian Functioning Brenner Tumor Associated With Endometrial Carcinoma and Endometriosis (Roncati-Manenti Triad).
Roncati L; Manenti A; Pusiol T; Piscioli F; Barbolini G; Maiorana A
Int J Gynecol Cancer; 2016 Oct; 26(8):1461-4. PubMed ID: 27465894
[TBL] [Abstract][Full Text] [Related]
18. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
Mylonas I
Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of pmTOR expression in endometrioid endometrial carcinoma.
Choi CH; Lee JS; Kim SR; Kim TJ; Lee JW; Kim BG; Bae DS
Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):207-10. PubMed ID: 20727662
[TBL] [Abstract][Full Text] [Related]
20. 'Minimal deviation' endometrioid carcinoma with oncocytic change of the endometrium.
Mai KT; Yazdi HM; Boone SA
Arch Pathol Lab Med; 1995 Aug; 119(8):751-4. PubMed ID: 7544107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
